HAL (France)open access
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer
18F-FDG MATV Ovarian cancer PERCIST PET, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 665118
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.